Related Experiment Video
Updated: Sep 25, 2025

09:30
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.5K
Aptasensors for Cancerous Exosome Detection
Jin Li1, Sitao Xie1, Fengli Qu2
1The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Methods in Molecular Biology (Clifton, N.J.)
|April 25, 2022
Summary
Cancerous exosomes hold promise for early cancer diagnosis and therapy. Aptamer-based biosensors (aptasensors) offer advanced detection of these exosomes by targeting specific biomarkers, paving the way for improved cancer diagnostics.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Diagnostics
Background:
- Cancerous exosomes contain multiple biomarkers, making them valuable targets for early cancer detection and treatment.
- Aptamers, with their high affinity and specificity, are effective molecular recognition tools for biomarker identification.
- Aptasensors are emerging as powerful tools for detecting cancerous exosomes.
Purpose of the Study:
- To review recent advancements in aptasensor technology for the detection of cancerous exosomes.
- To discuss the significance and potential of cancerous exosomes in cancer diagnosis and therapy.
- To summarize conventional aptasensor strategies focusing on biomarker recognition and signal detection.
Main Methods:
- Review of literature on aptamer-based biosensors (aptasensors) for exosome detection.
- Analysis of biomarker recognition strategies employed in aptasensors.
- Evaluation of signal collection methods used in aptasensor platforms for exosome detection.
Main Results:
- Aptasensors demonstrate significant potential for sensitive and specific detection of cancerous exosomes.
- Various aptasensor designs have been developed, leveraging aptamers for precise biomarker targeting.
- Different signal transduction mechanisms enhance the detectability of exosomes.
Conclusions:
- Aptasensors represent a promising technology for the early diagnosis and potential therapy of cancer through exosome detection.
- Continued research in aptasensor design and biomarker discovery will further enhance their clinical utility.
- Future directions include developing novel aptasensors for more accurate and efficient cancerous exosome detection.

